Publications by authors named "Simon Bayle"

Claim this Profile
U
Unveiling the dual reactivity of nanoscaled PuO sonicated in oxygenated aqueous solutions.
Julien Margate, Matthieu Virot, Thomas Dumas, Simon Bayle, Denis Menut

Ultrason Sonochem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic effects of combined BET and FAK inhibition against Vestibular Schwannomas in NF2-related Schwannomatosis.
Maria A González-Rodriguez, Scott Troutman, Simon Bayle, Daniel K Lester, Matthew Grove

Oncogene· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronicles of plutonium peroxides: spectroscopic characterization of a new peroxo compound of Pu(IV).
Julien Margate, Simon Bayle, Thomas Dumas, Elodie Dalodière, Christelle Tamain

Chem Commun (Camb)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties.
Alisa Morozova, Sean Chin Chan, Simon Bayle, Luxin Sun, Dylan Grassie

Eur J Med Chem· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uranium Speciation in a Chalky Soil.
Simon Bayle, Maria Rosa Beccia, Christophe Moulin, Pier Lorenzo Solari, Christophe Den Auwer

Environ Sci Technol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Based Development of Isoform-Selective Inhibitors of Casein Kinase 1ε vs Casein Kinase 1δ.
Jun Yong Choi, Yoshihiko Noguchi, James M Alburger, Simon Bayle, Eugene Chung

J Med Chem· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma.
Vincent Law, Zhihua Chen, Francesca Vena, Inna Smalley, Robert Macaulay, Simon Bayle

Neuro Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Casein Kinase 1 Delta Sensitizes Pancreatic and Bladder Cancer Cells to Gemcitabine Treatment by Upregulating Deoxycytidine Kinase.
Francesca Vena, Simon Bayle, Ainhoa Nieto, Victor Quereda, Massimiliano Aceti

Mol Cancer Ther· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer.
Victor Quereda, Simon Bayle, Francesca Vena, Sylvia M Frydman, Andrii Monastyrskyi

Cancer Cell· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitors.
Andrii Monastyrskyi, Simon Bayle, Victor Quereda, Wayne Grant, Michael Cameron

Bioorg Med Chem Lett· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis